{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:37:32Z","timestamp":1761100652967},"reference-count":25,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Isotype switch commonly follows onset of somatic hypermutation in the germinal center (GC), with activation-induced cytidine deaminase (AID) as a prerequisite. Mantle cell lymphoma (MCL) with t(11;14) includes a subset with unmutated (UM) and a minor subset with mutated (MUT) VH genes. Here, we investigated whether switch events and AID expression occur in MCL. In 4 of 6 UM and 4 of 7 MUT MCLs, alternative tumor-derived C\u03b3,\u03b1,\u03f5 transcripts were identified. AID transcripts, including a splice variant, were common to both subsets. AID expression correlated with switch in 8 of 8 cases, but in 3 of 5 cases it occurred with switch absent. Circle transcripts (I\u03b3-C\u03bc\/I\u03b1-C\u03bc) were identified in 5 of 7 evaluated cases. In 1 of 12 cases, 12% of tumor cells expressed immunoglobulin L-restricted surface IgA. Ongoing switch recombination events appear to be a feature of MCL, likely restricted to a minor tumor subpopulation, with occasional variant sIg expression. UM MCLs implicate origins from pre-GC B cells and reveal switch events at ectopic sites. (Blood. 2004;103:2795-2798)<\/jats:p>","DOI":"10.1182\/blood-2003-05-1632","type":"journal-article","created":{"date-parts":[[2003,10,14]],"date-time":"2003-10-14T00:18:45Z","timestamp":1066090725000},"page":"2795-2798","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":26,"title":["Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events"],"prefix":"10.1182","volume":"103","author":[{"given":"Gavin","family":"Babbage","sequence":"first","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Cancer Sciences Division, Southampton University Hospitals, Southampton, United Kingdom; and Laboratoire d'Hematologie, Institut de biologie des hopitaux, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Garand","sequence":"additional","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Cancer Sciences Division, Southampton University Hospitals, Southampton, United Kingdom; and Laboratoire d'Hematologie, Institut de biologie des hopitaux, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"Robillard","sequence":"additional","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Cancer Sciences Division, Southampton University Hospitals, Southampton, United Kingdom; and Laboratoire d'Hematologie, Institut de biologie des hopitaux, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Zojer","sequence":"additional","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Cancer Sciences Division, Southampton University Hospitals, Southampton, United Kingdom; and Laboratoire d'Hematologie, Institut de biologie des hopitaux, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freda K.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Cancer Sciences Division, Southampton University Hospitals, Southampton, United Kingdom; and Laboratoire d'Hematologie, Institut de biologie des hopitaux, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surinder S.","family":"Sahota","sequence":"additional","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Cancer Sciences Division, Southampton University Hospitals, Southampton, United Kingdom; and Laboratoire d'Hematologie, Institut de biologie des hopitaux, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021217352069600_REF1","unstructured":"Swerdlow SH, Berger F, Isaacson PI, et al. Mantle cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Wardiman JW, eds. World Health Organisation Classification of Tumours. Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001: 168-174."},{"key":"2020021217352069600_REF2","unstructured":"Welzel N, Trang L, Marculescu R, et al. Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions:implications for the mechanism of translocation and the origin of mantle cell lymphoma. Cancer Res. 2001;61: 1629-1636."},{"key":"2020021217352069600_REF3","doi-asserted-by":"crossref","unstructured":"Lovec H, Grzeschiczek A, Kowalski MB, Moroy T. Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 1994;13: 3487-3495.","DOI":"10.1002\/j.1460-2075.1994.tb06655.x"},{"key":"2020021217352069600_REF4","doi-asserted-by":"crossref","unstructured":"Camacho FI, Algara P, Rodriguez A, et al. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood. 2003;101: 4042-4046.","DOI":"10.1182\/blood-2002-11-3456"},{"key":"2020021217352069600_REF5","doi-asserted-by":"crossref","unstructured":"Orchard J, Garand R, Davis Z, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003;101: 4975-4981.","DOI":"10.1182\/blood-2002-06-1864"},{"key":"2020021217352069600_REF6","doi-asserted-by":"crossref","unstructured":"Kienle D, Kroeber A, Katzenberger T, et al. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood. 2003;102: 3003-3009.","DOI":"10.1182\/blood-2003-05-1383"},{"key":"2020021217352069600_REF7","doi-asserted-by":"crossref","unstructured":"Berek C. The development of B cells and the B-cell repertoire in the microenvironment of the germinal center. Immunol Rev. 1992;126: 5-19.","DOI":"10.1111\/j.1600-065X.1992.tb00628.x"},{"key":"2020021217352069600_REF8","doi-asserted-by":"crossref","unstructured":"Liu YJ, Malisan F, de Bouteiller O, et al. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity. 1996;4: 241-250.","DOI":"10.1016\/S1074-7613(00)80432-X"},{"key":"2020021217352069600_REF9","doi-asserted-by":"crossref","unstructured":"Honjo T, Kinoshito K, Muramatsu M. Molecular mechanisms of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol. 2002;20: 165-196.","DOI":"10.1146\/annurev.immunol.20.090501.112049"},{"key":"2020021217352069600_REF10","doi-asserted-by":"crossref","unstructured":"Kinoshita K, Harigai M, Fagarasan S, Muramatsu M, Honjo T. A hallmark of active class switch recombination: transcripts directed by I promoters on looped-out circular DNAs. Proc Natl Acad Sci U S A. 2001;98: 12620-12623.","DOI":"10.1073\/pnas.221454398"},{"key":"2020021217352069600_REF11","doi-asserted-by":"crossref","unstructured":"Perlmutter AP, Gilbert W. Antibodies of the secondary response can be expressed without switch recombination in normal mouse B cells. Proc Natl Acad Sci U S A. 1984;81: 7189-7193.","DOI":"10.1073\/pnas.81.22.7189"},{"key":"2020021217352069600_REF12","doi-asserted-by":"crossref","unstructured":"Mizuta TR, Suzuki N, Shimizu A, Honjo T. Duplicated variable region genes account for double isotype expression in a human leukemic B-cell line that gives rise to single isotype-expressing cells. J Biol Chem. 1991;266: 12514-12521.","DOI":"10.1016\/S0021-9258(18)98929-5"},{"key":"2020021217352069600_REF13","doi-asserted-by":"crossref","unstructured":"Muto T, Muramatsu M, Taniwaki M, Kinoshita K, Honjo T. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics. 2000;68: 85-88.","DOI":"10.1006\/geno.2000.6268"},{"key":"2020021217352069600_REF14","doi-asserted-by":"crossref","unstructured":"Nagumo H, Agematsu K, Kobayashi N, et al. The different process of class switching and somatic hypermutation; a novel analysis by CD27- naive B cells. Blood. 2002;99: 567-575.","DOI":"10.1182\/blood.V99.2.567"},{"key":"2020021217352069600_REF15","doi-asserted-by":"crossref","unstructured":"Cerutti A, Zan H, Kim EC, et al. Ongoing in vivo class switch DNA recombination in chronic lymphocytic leukemia B cells. J Immunol. 2002;169: 6594-6603.","DOI":"10.4049\/jimmunol.169.11.6594"},{"key":"2020021217352069600_REF16","doi-asserted-by":"crossref","unstructured":"Oppezzo P, Vuillier F, Vasconcelos Y, et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood. 2003;101: 4029-4032.","DOI":"10.1182\/blood-2002-10-3175"},{"key":"2020021217352069600_REF17","doi-asserted-by":"crossref","unstructured":"Sahota SS, Forconi F, Ottensmeier CH, et al. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood. 2002;100: 1505-1507.","DOI":"10.1182\/blood.V100.4.1505.h81602001505_1505_1507"},{"key":"2020021217352069600_REF18","doi-asserted-by":"crossref","unstructured":"Revy P, Muto T, Levy Y, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102: 565-575.","DOI":"10.1016\/S0092-8674(00)00079-9"},{"key":"2020021217352069600_REF19","doi-asserted-by":"crossref","unstructured":"McCarthy H, Wierda WG, Barron LL, et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor prognosis chronic lymphocytic leukemia. Blood. 2003;101: 4903-4908.","DOI":"10.1182\/blood-2002-09-2906"},{"key":"2020021217352069600_REF20","doi-asserted-by":"crossref","unstructured":"Greeve J, Philipsen A, Krause K, et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood. 2003;101: 3574-3580.","DOI":"10.1182\/blood-2002-08-2424"},{"key":"2020021217352069600_REF21","unstructured":"Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, van Noesel CJ. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res. 2003;63: 3894-3898."},{"key":"2020021217352069600_REF22","doi-asserted-by":"crossref","unstructured":"Manis JP, Tian M, Alt FW. Mechanism and control of class-switch recombination. Trends Immunol. 2002;23: 31-39.","DOI":"10.1016\/S1471-4906(01)02111-1"},{"key":"2020021217352069600_REF23","doi-asserted-by":"crossref","unstructured":"Toellner KM, Gulbranson-Judge A, Taylor DR, Sze DM, MacLennan IC. Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med. 1996;183: 2303-2312.","DOI":"10.1084\/jem.183.5.2303"},{"key":"2020021217352069600_REF24","doi-asserted-by":"crossref","unstructured":"MacLennan IC, Toellner KM, Cunningham AF, et al. Extrafollicular antibody responses. Immunol Rev. 2003;194: 8-18.","DOI":"10.1034\/j.1600-065X.2003.00058.x"},{"key":"2020021217352069600_REF25","doi-asserted-by":"crossref","unstructured":"Vaandrager JW, Schuuring E, Kluin-Nelemans HC, Dyer MJ, Raap AK, Kluin PM. DNA fiber fluorescence in situ hybridization analysis of immunoglobulin class switching in B-cell neoplasia: aberrant CH gene rearrangements in follicle center-cell lymphoma. Blood. 1998;92: 2871-2878.","DOI":"10.1182\/blood.V92.8.2871"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/7\/2795\/1696915\/zh800704002795.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/7\/2795\/1696915\/zh800704002795.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:49:32Z","timestamp":1623458972000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/7\/2795\/18249\/Mantle-cell-lymphoma-with-t1114-and-unmutated-or"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-05-1632","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}